D. Lockner

2.2k total citations
68 papers, 1.5k citations indexed

About

D. Lockner is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, D. Lockner has authored 68 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 18 papers in Internal Medicine and 15 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in D. Lockner's work include Venous Thromboembolism Diagnosis and Management (18 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (8 papers). D. Lockner is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (18 papers), Atrial Fibrillation Management and Outcomes (11 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (8 papers). D. Lockner collaborates with scholars based in Sweden, Netherlands and Czechia. D. Lockner's co-authors include E. Törnebohm, Göran Bratt, S. Granqvist, W. Åberg, Sam Schulman, Christer Paul, Margareta Holmström, Per Lindmarker, Hans Johnsson and A. Juhlin‐Dannfelt and has published in prestigious journals such as Nature, Cancer and British Journal of Cancer.

In The Last Decade

D. Lockner

67 papers receiving 1.3k citations

Peers

Countries citing papers authored by D. Lockner

Since Specialization

Citations

This map shows the geographic impact of D. Lockner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Lockner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Lockner more than expected).

Fields of papers citing papers by D. Lockner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Lockner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Lockner. The network helps show where D. Lockner may publish in the future.

Co-authorship network of co-authors of D. Lockner

This figure shows the co-authorship network connecting the top 25 collaborators of D. Lockner. A scholar is included among the top collaborators of D. Lockner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Lockner. D. Lockner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Entwicklung und Perspektiven der niedermolekularen Heparine 1999 ·Phlebologie ·D. Lockner	1
2	α‐2a interferon therapy and antibody formation in patients with essential thrombocythemia and polycythemia vera with thrombocytosis 1995 ·American Journal of Hematology ·(unknown), Mats Merup, D. Lockner, Christer Paul	10
3	A retrospective analysis of bleeding complications in 438 patients with acute leukaemia during the years 1972–1991 1993 ·European Journal Of Haematology ·E. Törnebohm, D. Lockner, Christer Paul	47
4	Electrical impedance and erythrocyte sedimentation rate (ESR) of blood 1993 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·(unknown), D. Lockner	24
5	Bleeding complications and coagulopathy in acute leukaemia 1992 ·Leukemia Research ·E. Törnebohm, Margareta Blombäck, D. Lockner, Nils Egberg, Christer Paul	16
6	Double-Blind, Randomized Comparison of Systemic Continuous Infusion of 0.25 Versus 0.50 mg/kg/24 h of Alteplase over 3 to 7 Days for Treatment of Deep Venous Thrombosis in Heparinized Patients: Results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) Trial 1992 ·Thrombosis and Haemostasis ·Henri Bounameaux, Jan Dirk Banga, Erich Bluhmki, S Coccheri, (unknown), (unknown), D. Lockner, F Mahler, J. Ninet, P A Schneider, A de Torrenté, J. van der Meer, (unknown)	26
7	Elastase Activity in Leukemic Cells 1992 ·Pathophysiology of Haemostasis and Thrombosis ·E. Törnebohm, D. Lockner, Christer Paul, Nils Egberg	1
8	Treatment of myelodysplastic syndromes with recombinant human erythropoietin 1991 ·European Journal Of Haematology ·(unknown), Gunnar Birgegård, D. Lockner, C. Helmers, Åke Öst, Leif Wide	47
9	Fatal pulmonary embolism caused by streptokinase treatment of deep venous thrombosis of the leg? 1990 ·Journal of Internal Medicine ·Margareta Holmström, Göran Bratt, E. Törnebohm, (unknown), D. Lockner	5
10	Two Daily Subcutaneous Injections of Fragmin as Compared with Intravenous Standard Heparin in the Treatment of Deep Venous Thrombosis (DVT) 1990 ·Thrombosis and Haemostasis ·Göran Bratt, W. Åberg, Margareta Johansson, E. Törnebohm, S. Granqvist, D. Lockner	122
11	A Comparison Between Low Molecular Weight Heparin (KABI 2165) and Standard Heparin in the Intravenous Treatment of Deep Venous Thrombosis 1985 ·Thrombosis and Haemostasis ·Göran Bratt, E. Törnebohm, S. Granqvist, W. Åberg, D. Lockner	125
12	Relationship Between Thromboembolic Complications and Intensity of Treatment During Long-Term Prophylaxis with Oral Anticoagulants Following DVT 1985 ·Thrombosis and Haemostasis ·Sam Schulman, D. Lockner	18
13	A Comparative Randomized Trial of Low-Dose Versus High-Dose Streptokinase in Deep Vein Thrombosis of the Thigh 1984 ·Thrombosis and Haemostasis ·Sam Schulman, D. Lockner, S. Granqvist, Göran Bratt, Christer Paul, Dag Nyman	40
14	Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cells 1979 ·Cancer Chemotherapy and Pharmacology ·Christer Paul, C. Peterson, Gösta Gahrton, D. Lockner	23
15	L‐Asparaginase and Prednisolone Pretreatment Followed by Rubidomycin and Cytosine Arabinoside for Induction of Remission in Adult Patients with Acute Myeloblastic Leukaemia 1975 ·Scandinavian Journal of Haematology ·A.‐M. Udén, G. Brenning, L. Engstedt, S. Franzén, Gösta Gahrton, B Gullbring, G. Holm, S Höglund, S. Jameson, A. Killander, D. Killander, D. Lockner, (unknown), Jan Palmblad, Peter Reizenstein, (unknown), (unknown), B. Wadman, L Wide	11
16	Quantitation of Erythropoiesis by a New Method IV. Studies Using ⁵⁹Fe and DF³²P Simultaneously in Haematological Diseases 1974 ·Scandinavian Journal of Haematology ·D. Lockner	4
17	Radiosensitivity of Haemopoiesis in Fish 1964 ·International Journal of Radiation Biology and Related Studies in Physics Chemistry and Medicine ·Knut Sletten, D. Lockner, G. Hevesy	6
18	Studies on Cancer Anaemia 1963 ·British Journal of Cancer ·D. Lockner, Knut Sletten, (unknown)	13
19	Klinische Untersuchungen zur Krebsanämie 1960 ·Acta Haematologica ·D. Lockner	8
20	Sites of the Physiological Breakdown of the Red Blood Corpuscles 1958 ·Nature ·Gerald Ehrenstein, D. Lockner	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact